Henry Schein, Inc. (NASDAQ:HSIC)‘s stock had its “buy” rating reiterated by equities research analysts at UBS AG in a research report issued to clients and investors on Friday, www.tipranks.com reports.
HSIC has been the topic of a number of other reports. Credit Suisse Group reissued a “hold” rating and set a $80.00 price target on shares of Henry Schein in a report on Thursday, July 13th. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $102.00 price target on the stock in a report on Thursday, May 25th. Stifel Nicolaus reissued a “hold” rating on shares of Henry Schein in a report on Thursday, July 6th. Piper Jaffray Companies assumed coverage on Henry Schein in a report on Monday, June 12th. They set a “neutral” rating and a $100.00 price target on the stock. Finally, Jefferies Group LLC reissued a “hold” rating and set a $88.50 price target on shares of Henry Schein in a report on Friday, July 21st. One analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $93.30.
Shares of Henry Schein (NASDAQ:HSIC) traded down 1.42% during trading on Friday, reaching $81.70. The company’s stock had a trading volume of 993,237 shares. Henry Schein has a 12-month low of $73.11 and a 12-month high of $93.50. The company has a market cap of $6.46 billion, a PE ratio of 11.94 and a beta of 1.10. The company has a 50 day moving average of $170.49 and a 200 day moving average of $175.55.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 8th. The company reported $0.88 EPS for the quarter, beating the Zacks’ consensus estimate of $0.86 by $0.02. The business had revenue of $3.06 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period last year, the firm earned $0.82 earnings per share. On average, analysts anticipate that Henry Schein will post $7.27 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Henry Schein, Inc. (HSIC) Stock Rating Reaffirmed by UBS AG” was originally posted by TrueBlueTribune and is the property of of TrueBlueTribune. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.truebluetribune.com/2017/09/17/ubs-ag-reiterates-buy-rating-for-henry-schein-inc-hsic.html.
In other news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the sale, the senior vice president now directly owns 17,841 shares of the company’s stock, valued at $3,077,750.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.27% of the company’s stock.
Several hedge funds have recently modified their holdings of the company. Vanguard Group Inc. increased its holdings in shares of Henry Schein by 3.0% in the second quarter. Vanguard Group Inc. now owns 8,086,317 shares of the company’s stock worth $1,479,959,000 after purchasing an additional 236,862 shares during the last quarter. FMR LLC increased its holdings in shares of Henry Schein by 0.4% in the second quarter. FMR LLC now owns 6,921,367 shares of the company’s stock worth $1,266,749,000 after purchasing an additional 24,935 shares during the last quarter. BlackRock Inc. increased its holdings in shares of Henry Schein by 1.8% in the second quarter. BlackRock Inc. now owns 5,696,685 shares of the company’s stock worth $1,042,607,000 after purchasing an additional 101,406 shares during the last quarter. State Street Corp increased its holdings in shares of Henry Schein by 1.3% in the first quarter. State Street Corp now owns 3,675,674 shares of the company’s stock worth $624,760,000 after purchasing an additional 48,469 shares during the last quarter. Finally, Mackenzie Financial Corp increased its holdings in shares of Henry Schein by 4.7% in the first quarter. Mackenzie Financial Corp now owns 1,728,230 shares of the company’s stock worth $293,747,000 after purchasing an additional 76,794 shares during the last quarter. 89.05% of the stock is currently owned by hedge funds and other institutional investors.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.